logo
CanyamAI summaries for academic research
language
MobileMobile
  • Phone FeatureWeChat Mini Program
EnglishEnglish
noticeNotice
BlogBlog
delete
arrow
Back
T

Tetsuya Mitsudomi

kindai university (kinki university)

113H-index
1.0KPaper Count
6.2WCitation Count
Published Papers 175
Publication Date
logo
Analysis of Peripheral T Cell Profiling and Plasma Proteomics in Advanced NSCLC Patients Treated With Atezolizumab
errCancer Science
IF4.3
err2026-02-02
err0
errOAAI
errAtsuto Mouri; Hiroshi Kagamu; Koji Tamada; Makoto Nishio; Hiroaki Akamatsu; Yasushi Goto; Hidetoshi Hayashi; Satoru Miura; Akihiko Gemma; Ichiro Yoshino; Toshihiro Misumi; Ryota Saito; Noriko Yanagitani; Fujita Masaki; Hiroshi Nokihara; Kazumi Nishino; Masahiro Seike; Tetsunari Hase; Osamu Hataji; Hiroaki Takeoka; Yosuke Kawashima; Hirotaka Kuroki; Masamichi Sugimoto; Hiroshi Kuriki; Tetsuya Mitsudomi
errShare
errSave
Response to Letter to the Editor
errJournal of Thoracic Oncology
IF20.8
err2025-12-03
err0
PREAI
errTetsuya Mitsudomi; David Harpole
errShare
errSave
Low OLFM1 and BMP6 Expression Predicts Recurrence in Early-Stage Nonsquamous NSCLC with Pure Solid Tumor Appearance
errCancer Research Communications
IF0
err2025-12-01
err0
errOAAI
errSuda, Kenichi; Yoshida, Yukihiro; Sato, Hidenori; Ohara, Shuta; Hamada, Akira; Yotsukura, Masaya; Shiraishi, Kouya; Hamamoto, Ryuji; Chiba, Yasutaka; Kohno, Takashi; Yatabe, Yasushi; Watanabe, Shun-ichi; Tsutani, Yasuhiro; Mitsudomi, Tetsuya
errShare
errSave
Efficacy of Conventional and Novel Tyrosine Kinase Inhibitors for Uncommon EGFR Mutations—An In Vitro Study
errCells 2025, Vol. 14, Page 1386
IF5.2
err2025-09-20
err0
errOAAI
errHana Oiki; Kenichi Suda; Akira Hamada; Toshio Fujino; Keiko Obata; Yoshihisa Kobayashi; Kazuko Sakai; Shota Fukuda; Shuta Ohara; Masaoki Ito; Junichi Soh; Kazuto Nishio; Tetsuya Mitsudomi; Yasuhiro Tsutani
errShare
errSave
Long-Term Safety and Effectiveness of Durvalumab in Unresectable Stage III non-small cell lung cancer in Japan: A Multicenter Prospective Study (AYAME)
errJournal of Thoracic Oncology
IF20.8
err2025-08-18
err0
errOAAI
errHirotsugu Kenmotsu; Yoshinobu Saito; Kiichiro Ninomiya; Shinya Uematsu; Burak Akdemir; Ayako Fukui; Ryo Koto; Masakazu Fujiwara; Chikako Iwao; Hiroshi Kitagawa; Ichiro Yoshino; Akihiko Gemma; Tetsuya Mitsudomi; Nobuyuki Yamamoto
errShare
errSave
Clinical Utility of the 5-Point Visual Deauville Score for Preoperative Evaluation in Stage I NSCLC: A Multicenter Retrospective Study
errthoracic and cardiovascular surgery
IF0
err2025-07-16
err0
PREAI
errTomoyo Fukami; Akira Hamada; Kenichi Suda; Hayato Kaida; Yukihiro Yoshida; Kazuhiro Kitajima; Kimiteru Ito; Tetsuro Sekine; Kyoshiro Takegahara; Hiromitsu Daisaki; Masaki Hashimoto; Takanobu Kabasawa; Takashi Yamasaki; Seiichi Hirota; Jitsuo Usuda; Kazunari Ishii; Junichi Soh; Tetsuya Mitsudomi; Yasuhiro Tsutani
errShare
errSave
Single-cell spatial analysis with Xenium reveals anti-tumour responses of CXCL13 + T and CXCL9+ cells after radiotherapy combined with anti-PD-L1 therapy
errBritish Journal of Cancer
IF6.8
err2025-07-16
err0
errOAAI
errShunsuke A. Sakai; Hidekazu Oyoshi; Masaki Nakamura; Tetsuro Taki; Kotaro Nomura; Hidehiro Hojo; Hidenari Hirata; Atsushi Motegi; Yuka Nakamura; Junko Zenkoh; Keiju Aokage; Akira Hamada; Motohiro Kojima; Takeshi Kuwata; Katsuya Tsuchihara; Tetsuo Akimoto; Junichi Soh; Tetsuya Mitsudomi; Masahiro Tsuboi; Genichiro Ishii; Yutaka Suzuki; Ayako Suzuki; Riu Yamashita; Shun-Ichiro Kageyama
errShare
errSave
Surgical Outcomes with Neoadjuvant Durvalumab Plus Chemotherapy Followed by Adjuvant Durvalumab in Resectable NSCLC
errJournal of Thoracic Oncology
IF20.8
err2025-06-20
err0
PREAI
errTetsuya Mitsudomi; John V. Heymach; Martin Reck; Janis M. Taube; Shugeng Gao; Yoshitsugu Horio; Jian You; Gaofeng Li; Dinh Van Luong; Somcharoen Saeteng; Fumihiro Tanaka; Stefan B. Watzka; Laszlo Urban; Zsuzsanna Szalai; Hiroaki Akamatsu; Jin Hyoung Kang; Francisco J. Orlandi; Guzel Z. Mukhametshina; Andreas Pircher; Carlos Henrique Andrade Teixeira; Mike Aperghis; Gary J. Doherty; Ruth Doake; Tamer M. Fouad; David Harpole
errShare
errSave
Advances in Lung Cancer Basic and Translational Research in 2025 – Overview and Perspectives Focusing on NSCLC
errJournal of Thoracic Oncology
IF20.8
err2025-06-03
err0
PREAI
errCeline Mascaux; Triparna Sen; Montse Sanchez-Cespedes; Sandra Ortiz-Cuaran; Yohan Bossé; Floris Dammeijer; Milena Cavic; Martin P. Barr; Surein Arulananda; Ricardo Armisen; Alice H. Berger; Fabrizio Bianchi; David P. Carbone; Ferdinando Cerciello; William W. Lockwood; Tetsuya Mitsudomi; Shuta Ohara; Katerina Politi; Sida Qin; Laila C. Roisman; Robert Samstein; Ferdinandos Skoulidis; Aaron C. Tan; Anish Thomas; Jianjun Zhang; Murry W. Wynes; Thomas John; Ming Sound Tsao
errShare
errSave
Neoadjuvant Concurrent Chemo–Immuno–Radiation Therapy Followed by Surgery and Adjuvant Immunotherapy for Resectable Stage III N2 NSCLC: Primary Results From the SQUAT Trial (WJOG 12119L)
errJournal of Thoracic Oncology
IF20.8
err2025-04-09
err0
PREAI
errAkira Hamada; Junichi Soh; Akito Hata; Kiyoshi Nakamatsu; Mototsugu Shimokawa; Yasushi Yatabe; Jun Suzuki; Masahiro Tsuboi; Hidehito Horinouchi; Yuichi Sakairi; Masayuki Tanahashi; Shinichi Toyooka; Morihito Okada; Natusmi Matsuura; Hisayuki Shigematsu; Yasumasa Nishimura; Nobuyuki Yamamoto; Kazuhiko Nakagawa; Tetsuya Mitsudomi
errShare
errSave
Clinical Significance of Perioperative Minimal Residual Disease Detected by Circulating Tumor DNA in Patients With Lung Cancer With a Long Follow-up Data: An Exploratory Study
errJTO CLINICAL AND RESEARCH REPORTS
IF3.5
err2025-03-01
err0
errOAAI
errOhara, Shuta; Suda, Kenichi; Sudhaman, Sumedha; Hamada, Akira; Chiba, Masato; Shimoji, Masaki; Takemoto, Toshiki; Kalashnikova, Ekaterina; Cheung, Samantha K.; Krainock, Michael; Feeney, Jordan; Sethi, Himanshu; Liu, Minetta C.; Soh, Junichi; Tsutani, Yasuhiro; Mitsudomi, Tetsuya
errShare
errSave
Longitudinal recurrence risk of adjuvant cytotoxic chemotherapy and gefitnib in resected lung cancer: A combined analysis of phase III studies
errLUNG CANCER
IF4.4
err2025-03-01
err0
errOAAI
errAkamatsu, Hiroaki; Nishikawa, Tomomi; Takeda, Yuriko; Misumi, Toshihiro; Aoki, Tadashi; Shoda, Hiroyasu; Yamashita, Motohiro; Sakakura, Noriaki; Daga, Haruko; Sugawara, Shunichi; Okishio, Kyoichi; Kenmotsu, Hirotsugu; Yamamoto, Nobuyuki; Tada, Hirohito; Tsuboi, Masahiro; Mitsudomi, Tetsuya
errShare
errSave
Sunvozertinib: shining light on lung cancer's exon 20 fight
errTRANSLATIONAL LUNG CANCER RESEARCH
IF3.5
err2025-02-01
err0
errOAAI
errMitsudomi, Tetsuya
errShare
errSave
Savolitinib in NSCLC: progress in the MET exon 14 journey
errLANCET RESPIRATORY MEDICINE
IF32.8
err2024-12-01
err0
PREAI
errMitsudomi, Tetsuya
errShare
errSave
Real-World Pharmacokinetics, Effectiveness, and Safety of Atezolizumab in Patients With Unresectable Advanced or Recurrent NSCLC: An Exploratory Study of J-TAIL
errJTO CLINICAL AND RESEARCH REPORTS
IF3.5
err2024-07-01
err1
errOAAI
errYagishita, Shigehiro; Goto, Yasushi; Nishio, Makoto; Akamatsu, Hiroaki; Hayashi, Hidetoshi; Miura, Satoru; Tamada, Koji; Kagamu, Hiroshi; Hamada, Akinobu; Ohuchi, Mayu; Gemma, Akihiko; Yoshino, Ichiro; Misumi, Toshihiro; Hata, Akito; Hara, Satoshi; Kijima, Takashi; Masaki, Fujita; Iwasawa, Shunichiro; Nakagawa, Shintaro; Tatsuno, Masahiro; Mitsudomi, Tetsuya
errShare
errSave
Potential Utility of a 4th-Generation EGFR-TKI and Exploration of Resistance Mechanisms-An In Vitro Study
errBIOMEDICINES
IF3.9
err2024-06-25
err2
errOAAI
errFukuda, Shota; Suda, Kenichi; Hamada, Akira; Oiki, Hana; Ohara, Shuta; Ito, Masaoki; Soh, Junichi; Mitsudomi, Tetsuya; Tsutani, Yasuhiro
errShare
errSave
Associations of ctDNA levels during neoadjuvant treatment with pathological response in patients with resectable NSCLC from the phase 3 AEGEAN trial
errCANCER RESEARCH
IF16.6
err2024-04-05
err1
PREAI
errGale, Davina; Zhu, Zhou; Lai, Zhongwu; Reck, Martin; Harpole, David; Taube, Janis M.; Mitsudomi, Tetsuya; Hochmair, Maximilian; Winder, Thomas; Urban, Laszlo; Rodriguez-Cid, Jeronimo; Chu, Quincy; Chaft, Jamie; Stewart, Ross; Hodgson, Darren; Doherty, Gary J.; Heymach, John V.
errShare
errSave
Perioperative Durvalumab for Resectable Non-Small-Cell Lung Cancer
errNEW ENGLAND JOURNAL OF MEDICINE
IF78.5
err2023-11-02
err173
errOAAI
errHeymach, John V.; Harpole, David; Mitsudomi, Tetsuya; Taube, Janis M.; Galffy, Gabriella; Hochmair, Maximilian; Winder, Thomas; Zukov, Ruslan; Garbaos, Gabriel; Gao, Shugeng; Kuroda, Hiroaki; Ostoros, Gyula; Tran, Tho V.; You, Jian; Lee, Kang-Yun; Antonuzzo, Lorenzo; Papai-Szekely, Zsolt; Akamatsu, Hiroaki; Biswas, Bivas; Spira, Alexander; Crawford, Jeffrey; Le, Ha T.; Aperghis, Mike; Doherty, Gary J.; Mann, Helen; Fouad, Tamer M.; Reck, Martin
errShare
errSave
NOTCH1 and CREBBP co-mutations negatively affect the benefit of adjuvant therapy in completely resected EGFR-mutated NSCLC: translational research of phase III IMPACT study
errMOLECULAR ONCOLOGY
IF4.5
err2023-10-28
err3
errOAAI
errIkeda, Satoshi; Tsuboi, Masahiro; Sakai, Kazuko; Misumi, Toshihiro; Akamatsu, Hiroaki; Shoda, Hiroyasu; Sakakura, Noriaki; Nakamura, Atsushi; Ohde, Yasuhisa; Hayashi, Hidetoshi; Okishio, Kyoichi; Okada, Morihito; Yoshino, Ichiro; Okami, Jiro; Takahashi, Kazuhisa; Ikeda, Norihiko; Tanahashi, Masayuki; Tambo, Yuichi; Saito, Haruhiro; Toyooka, Shinichi; Inokawa, Hidetoshi; Chen-Yoshikawa, Toyofumi; Yokoyama, Toshihide; Okamoto, Tatsuro; Yanagitani, Noriko; Oki, Masahide; Takahama, Makoto; Sawa, Kenji; Tada, Hirohito; Nakagawa, Kazuhiko; Mitsudomi, Tetsuya; Nishio, Kazuto
errShare
errSave
Neoadjuvant nivolumab (N) plus chemotherapy (C) in the phase III CheckMate 816 study: 3-y results by tumor PD-L1 expression
errANNALS OF ONCOLOGY
IF65.4
err2023-10-01
err10
errOAAI
errPulla, M. Provencio; Forde, P. M.; Spicer, J. D.; Wang, C.; Lu, S.; Mitsudomi, T.; Awad, M. M.; Felip, E.; Broderick, S.; Swanson, S. J.; Brahmer, J. R.; Kerr, K. M.; Saylors, G.; Tanaka, F.; Chen, K. N.; Tran, M. P.; Cai, J. L.; Mahmood, J.; Meadows-Shropshire, S.; Girard, N.
errShare
errSave

Research Directions

No research directions
Co-authors
Cooperation Journals
M
Meir J. Stampfer
H-index: 223 · Papers: 1.3K
D
David J. Hunter
H-index: 204 · Papers: 2.5K
W
William D. Travis
H-index: 176 · Papers: 1.1K
C
Charles S. Fuchs
H-index: 171 · Papers: 1.7K
S
Stephen J. Chanock
H-index: 170 · Papers: 2.2K
View more